Search clinical trials for: Immunological profile

Total 16155 results

Peregrine Pharmaceuticals

Completed

Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C

Hepatitis C

United States
Memorial Sloan Kettering Cancer Center

Completed

Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC

Carcinoma, Non-Small-Cell Lung

United States
Tehran University of Medical Sciences
Hoffmann-La Roche

Completed

Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease

Behcet's Syndrome

Iran, Islamic Republic of
US Oncology Research
Fred Hutchinson Cancer Center; Chiron Corporation

Terminated

Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

United States
National Taiwan University Hospital

Completed

Bevacizumab and Long Acting Gas in Diabetic Vitrectomy

Proliferative Diabetic Retinopathy

Taiwan
Kanisa Pharmaceuticals

Completed

A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia

Leukemia, Myeloid
Sanofi

Completed

Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride

Diabetes Mellitus

France
Cedars-Sinai Medical Center
Genentech, Inc.; Biogen

Completed

Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation

Kidney Transplant

United States
Sheba Medical Center
Universitaire Ziekenhuizen KU Leuven

Unknown

The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD) (AMD)

Neovascular Age Related Macular Degeneration

Belgium, Israel
Regione Lombardia
Mario Negri Institute for Pharmacological Research; Istituto Clinico Humanitas

Unknown

Trastuzumab Optimization Trial in Breast Cancer (TOP)

Metastatic or Locally Advanced Breast Cancer

Italy
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Genomics of In-Stent Restenosis

In-Stent Restenosis | Vascular Disease

United States
National Institute of Allergy and Infectious Diseases...

Completed

An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies

Wegener's Granulomatosis

United States
National Cancer Institute (NCI)

Completed

Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas

Pancreatic Cancer | Pancreatic Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab

Stomach Neoplasms | Breast Neoplasms | Lung Neoplasms | Pancreatic Neoplasms | Colonic Neoplasms

United States
National Institute of Neurological Disorders and...

Completed

Potential Risk Factors for Stroke

Hypertension | Diabetes Mellitus | Hypercholesterolemia | Carotid Atherosclerosis | Cerebrovascular Accident

United States
National Institute of Arthritis and Musculoskeletal...

Completed

Humanized LL2IGG to Treat Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States
National Cancer Institute (NCI)

Completed

In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients

Lymphoma | Leukemia | Neoplasm | Immunologic Deficiency Syndrome

United States
University of Calgary
Pfizer

Unknown

ICA-CHAMP: Indo-Central Asian Cardiovascular Health Assessment and Management Program (ICA-CHAMP)

Cardiovascular Diseases | Hypertension | Hyperlipidemia

Canada
AstraZeneca

Completed

A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using Patients

Nausea | Heartburn | Acid Regurgitation | Upper Abdominal Pain
Shahid Beheshti University of Medical Sciences

Completed

Intravitreal Bevacizumab for Neovascular Glaucoma (IVB NVG)

Glaucoma | Neovascular

Iran, Islamic Republic of
University of Pittsburgh
Sunovion; American Academy of Sleep Medicine

Completed

Testing the Nocturnal Sleep Latency Profile in Primary Insomnia

Sleep Initiation and Maintenance Disorders | Primary Insomnia

United States
Millennium Pharmaceuticals, Inc.

Completed

VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma

Follicular Lymphoma | B-Cell Lymphoma | Marginal Lymphoma

United States
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients

HIV Infections

Spain, Italy
Genentech, Inc.

Completed

A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)

Non-Small-Cell Lung Carcinoma | Neoplasm Recurrence, Local

United States
University of Virginia
National Cancer Institute (NCI)

Terminated

Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Lymphoma

United States
Oncothyreon Canada Inc.

Completed

Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients

Breast Neoplasms

United States
Boston Children's Hospital
Sandra A. Daugherty Foundation

Completed

Inflammatory Profiles of Children at High Risk for Atherosclerosis

Inflammation | Cardiovascular Disease | Hypercholesterolemia | Metabolic Syndrome X

United States
Javelin Pharmaceuticals

Completed

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075 (Intranasal Morphine)

Healthy

United States
University of Michigan Rogel Cancer Center

Terminated

Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin's

United States
Sanofi

Completed

An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice

Diabetes Mellitus

Belgium
NSABP Foundation Inc
Amgen

Withdrawn

Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum

Neoplasm Metastasis | Rectal Cancer
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms

Postmenopause

United States
Amgen

Completed

Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)

Non-Hodgkin's Lymphoma
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaborators

Completed

Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer

Neoplasm Metastasis | Colorectal Cancer

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
AstraZeneca

Completed

Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma

Head and Neck Cancer

Hong Kong, Singapore
Unither Pharmaceuticals

Terminated

Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment

Ovarian Cancer
Unither Pharmaceuticals

Terminated

Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma

Ovarian Neoplasms

Canada, United States
Unither Pharmaceuticals

Terminated

A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma

Ovarian Neoplasms

United States
Unither Pharmaceuticals

Terminated

Clinical Trial for Ovarian Cancer (OvaRex®)

Ovarian Cancer

United States
Novartis

Completed

Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis

Atopic Dermatitis

United States
Università degli Studi dell'Insubria

Unknown

Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine

HIV Infections | Hypertension

Italy
Merck Sharp & Dohme LLC

Completed

A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet (LOCUST)

Hyperlipidemia
Karolinska University Hospital

Completed

Safety and Efficacy Study of Rituximab in Renal Transplantation

Renal Transplantation

Sweden
Tel-Aviv Sourasky Medical Center
Ministry of Health, Israel

Unknown

Autoantibodies and Clinical Symptoms in Infective Endocarditis Patients

Infective Endocarditis

Israel
Grupo Portugues de Estudo do Cancro do Pulmao

Unknown

Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC (Coimbra)

Carcinoma, Non-Small-Cell Lung

Portugal
Keio University

Terminated

Safety and Efficacy Study of Salvage Chemotherapy (R-ESHAP) to Treat Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin

Japan
LifeBridge Health

Completed

Flavonoid Effect on Activation and Stimulation of Thrombocytes, hsCRP and Lipid Profile (FEAST-CAL)

Healthy

United States
Assistance Publique - Hôpitaux de Paris

Completed

RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides

Wegener's Granulomatosis | Microscopic Polyangiitis | Churg-Strauss Syndrome

France
Mast Therapeutics, Inc.

Unknown

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Metastatic Colorectal Cancer | Rectal Cancer | Colon Cancer

United States, Former Serbia and Montenegro

3

Subscribe